TriWise Capital

Venture Capital Guangdong, China ·Founded 2015

Overview

TriWise Capital is an investment firm specializing in venture capital and M&A activities within China. The firm concentrates on early to middle-stage investments, particularly in the healthcare and biotechnology sectors. TriWise Capital has established a diverse portfolio, including investments in companies such as Akeso, Inc. and Qyuns Therapeutics Co., Ltd. The firm's team comprises former executives from various financial institutions, industry experts from leading corporations, and scholars from prominent academic institutions. TriWise Capital manages assets exceeding RMB3 billion and is committed to fostering innovation and growth in the Chinese market. The firm's investment strategy emphasizes original and value-driven investments, focusing on sectors with high growth potential. By leveraging its extensive network and expertise, TriWise Capital aims to identify and support companies that can achieve significant market impact. The firm operates with a philosophy that combines financial returns with contributions to industrial development, aiming to create value for both investors and the broader economy. TriWise Capital's approach is characterized by a commitment to excellence, integrity, and a deep understanding of the industries it invests in. Through its strategic investments and partnerships, TriWise Capital continues to play a pivotal role in the Chinese venture capital landscape, supporting the growth and success of innovative companies across various sectors. The firm's dedication to fostering entrepreneurship and technological advancement underscores its position as a key player in China's investment ecosystem.

Investment Focus

  • Focus on biological medicine
  • Early to middle stage companies
  • Innovative healthcare solutions
  • Focus on early to middle-stage companies
  • Preference for healthcare and biotechnology sectors
  • Commitment to original and value-driven investments
  • Emphasis on sectors with high growth potential
  • Interest in companies with significant market impact potential
  • Alignment with TriWise Capital's investment philosophy and values

Portfolio Companies

Akeso, Inc.Qyuns Therapeutics Co., Ltd.

Reach TriWise Capital directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about TriWise Capital

What sectors does TriWise Capital invest in?

TriWise Capital invests in Technology, Healthcare, Pharmaceuticals, Biotechnology, Pharmaceutical and Medical, and is based in Guangdong, China. TriWise Capital is listed as a venture capital in the ConnectSafely investor database.

What stage does TriWise Capital invest at?

TriWise Capital backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage.

Which regions does TriWise Capital invest in?

TriWise Capital invests across China.

What companies has TriWise Capital invested in?

TriWise Capital's portfolio includes Akeso, Inc. and Qyuns Therapeutics Co., Ltd..

Last updated · Source: ConnectSafely investor database